HomeCYAD • EBR
add
Celyad Oncology SA
Previous close
€0.58
Day range
€0.53 - €0.58
Year range
€0.21 - €1.22
Market cap
30.18M EUR
Avg Volume
48.69K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 86.00K | 196.55% |
Operating expense | 1.47M | -37.87% |
Net income | -1.39M | 40.95% |
Net profit margin | -1.62K | 80.09% |
Earnings per share | — | — |
EBITDA | -1.26M | 43.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.20M | -40.03% |
Total assets | 9.93M | -39.02% |
Total liabilities | 9.42M | -5.62% |
Total equity | 511.00K | — |
Shares outstanding | 41.77M | — |
Price to book | 58.00 | — |
Return on assets | -34.93% | — |
Return on capital | -244.88% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.39M | 40.95% |
Cash from operations | -1.42M | 58.54% |
Cash from investing | 7.50K | 102.69% |
Cash from financing | 404.00K | -91.46% |
Net change in cash | -1.01M | -199.85% |
Free cash flow | -943.50K | 29.43% |
About
Founded
2004
Headquarters
Website
Employees
12
